Login

Ownership

Who owns Oculis Holding AG, from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).

Stakes over 5%

Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.

LSP 7 Cooperatieve U.A., LSP 7 Management B.V. April 29, 2026

LSP 7 Cooperatieve U.A.: 11.8% · 6,950,294 shares — LSP 7 Management B.V.: 11.8% · 6,950,294 shares

BVCF IV, L.P., BEYEOTECH, BVCF IV GP, Ltd. March 27, 2026

BVCF IV, L.P.: 4.1% · 2,436,902 shares — BEYEOTECH: 4.1% · 2,436,902 shares — BVCF IV GP, Ltd.: 4.1% · 2,436,902 shares

2 more 5% stakes behind a free account

See every investor who has disclosed crossing 5% of Oculis Holding AG.

Sign up free

Super investors holding OCS

Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Oculis Holding AG they hold.

Investor Position value Shares % of their portfolio % of company As of
EQT Fund Management S.a r.l. $96.4M 6,950,294 11.18% June 30, 2026
Gildi - lifeyrissjodur $64.3M 2,430,401 32.62% March 31, 2026

81 more institutional holders behind a free account

See every manager reporting Oculis Holding AG, how much of the company they hold, and how big the position is inside their own portfolio.

Sign up free

Funds holding OCS

Funds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets.

Fund Position value % of net assets % of company As of
Eventide Healthcare & Life Sciences Fund $11.4M 0.72% March 31, 2026
ALPS Medical Breakthroughs ETF $1.5M 1.09% February 28, 2026

4 more funds behind a free account

See every fund holding Oculis Holding AG and what share of its net assets the position represents.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support